Search results
Make identity theft protection part of your monthly budget | Dave Ramsey
Gannett via AOL· 8 hours agoOn top of all that, what if they don’t have the money to fix things when they leave? It’ll...of their money, build wealth and enhance their lives. He also serves as CEO for ...
CyberArk stock maintains buy rating from TD Cowen By Investing.com
Investing.com· 3 hours agoThe firm's analysis suggests that identity security remains a top priority for Chief Information...
China's vast cyber trafficking network dupes Americans using fake shops
Fox News· 6 days agoA Chinese network running countless fake online shops has scammed over 800,000 people in the U.S....
IDX data removal service review
TechRadar· 4 days agoIDX is among the best identity theft protection and data removal services on the market in 2024, and there is some stiff competition. In operation since...
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It Ranks Among the...
Motley Fool via Yahoo Finance· 2 days agoAnalysts have also praised the company as a technology leader in identity threat detection and cloud...
Scammers’ New Way of Targeting Small Businesses: Impersonating Them
The Wall Street Journal· 4 days agoImitators also have fine-tuned their tactics, including by outbidding legitimate brands for top...
Ascension Healthcare Hack Traced to Employee Downloading Malicious File
PC Magazine· 3 hours agoThe ransomware attack on Ascension, a major US healthcare provider, has been traced to a malicious...
Election aftermath - Parliament impact on tech
Euronews via Yahoo News· 12 hours agoKolaja, a former software engineer and digital rights activist, is among three candidates from his native Czechia for the top role. Eva Maydell, EPP...
Ascension identifies how hacker gained access to systems after cyberattack
FOX23 News· 22 hours agoAscension St. John said the company has made progress in its investigation and recovery after a...
Scammers make millions selling nonexistent Ozempic, report finds
Newsweek· 19 hours agoPhishing attempts involving popular GLP-1 drugs—like Ozempic, Wegovy and Mounjaro—were up 183...